Doximity's 2026 Q1 Earnings: Key Contradictions on AI Investments, Revenue Cadence, and Client Engagement

AI investment and impact on revenue, revenue cadence expectations, AI tool integration and platform engagement, revenue recognition and client expansion, AI product opportunities and engagement are the key contradictions discussed in Doximity's latest 2026Q1 earnings call.}



Strong Financial Performance:
- Doximity reported a $146 million in revenue for Q1 of fiscal 2026, representing 15% year-on-year growth and a 4% beat from the high end of their guidance.
- The growth was driven by strong performance in new upsell season and increased adoption of new products and portal.

Network Growth and Engagement:
- Unique active users on the Doximity platform reached record highs in Q1, with over 1 million quarterly active prescribers using the newsfeed.
- This growth was supported by the launch of the Doximity AI Scribe and increased usage of AI tools, which saw a more than 5x year-on-year increase.

AI Integration Expansion:
- Doximity launched its AI Scribe product, with over 10,000 physicians aiding in beta testing, and integrated the Pathway acquisition into Doximity GPT.
- The integration of AI technology is aimed at making physicians more productive and improving patient care, contributing to increased user engagement and potential revenue generation.

Upsell Season and Client Portal Impact:
- Doximity saw a broad-based strength across all business aspects, with upsell from SMB clients growing over 100% year-over-year.
- This was attributed to the client portal, which provides insights into program performance, and an expanded commercial product portfolio.